Mateon Therapeutics Inc.

(MATN)

By |

Profile

Mateon Therapeutics Inc is a US-based biopharmaceutical company which is focused on the development of vascular disrupting agents (VDA), for the treatment of cancer. VDA targets the vasculature of cancer tumors and obstructs a tumor's blood supply without disrupting the blood supply to normal tissues. The company is engaged in developing clinical stage investigational drugs that is CA4P and OXi4503. CA4P s a reversible tubulin-binding agent that selectively targets endothelial cells, which make up the interior lining of blood vessel walls in solid tumors; and OXi4503 which is a novel, dual-mechanism VDA, to reduce tumor blood flow and it also forms a potentially anti-proliferative metabolite.

Contact Information

Website: www.mateon.com
Email: ir@oxigene.com
Main Phone: +1 650 635-7000
Address: 701 Gateway Boulevard
Address 2: Suite 210
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: OTCQB
CEO: Vuong Trieu
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Mateon Therapeutics Inc is a US-based biopharmaceutical company which is focused on the development of vascular disrupting agents (VDA), for the treatment of cancer. VDA targets the vasculature of cancer tumors and obstructs a tumor's blood supply without disrupting the blood supply to normal tissues. The company is engaged in developing clinical stage investigational drugs that is CA4P and OXi4503. CA4P s a reversible tubulin-binding agent that selectively targets endothelial cells, which make up the interior lining of blood vessel walls in solid tumors; and OXi4503 which is a novel, dual-mechanism VDA, to reduce tumor blood flow and it also forms a potentially anti-proliferative metabolite.

Contact Information

Website: www.mateon.com
Email: ir@oxigene.com
Main Phone: +1 650 635-7000
Address: 701 Gateway Boulevard
Address 2: Suite 210
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: OTCQB
CEO: Vuong Trieu
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.34 $ 0.10 (43.18%)
Last Price 0.34 Change $ 0.10 Change % 43.18 Tick N/A
Bid 0.22 Bid Size 2,500.00 Ask 0.34 Ask Size 2,500.00
Open 0.26 High 0.34 Low 0.26 Prev Close 0.24
Last Trade Volume 20,600 52 Wk Hi 0.34 52 Wk Low 0.05
Market Cap 27.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 82,450,664.00 EPS (TTM) -0.07 PE Ratio N/A Exchange OTCQB
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 9
Number of Buys 0 9
Number of Sells 0 0
Net Activity 0 2250000
Last 10 Buys Shares
William D. Schwieterman 1,000
William D. Schwieterman 1,000
William D. Schwieterman 1,000
Donald R Reynolds 1,000
Donald R Reynolds 1,000
Donald R Reynolds 1,000
Matthew M. Loar 1,000
Matthew M. Loar 1,000
Matthew M. Loar 1,000
Donald R Reynolds 1,000
Last 10 Sell Shares
Tamar D. Howson 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.55 0.55 0.55 0.55
Low Target Price Estimate 0.55 0.55 0.55 0.55
Mean Target Price Estimate 0.55 0.55 0.55 0.55
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/18/18 04/18/18 04/18/18 04/18/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3